Fig. 1
From: Treatment of mycophenolate-resistant immune-related organizing pneumonia with infliximab
Initial treatment of metastatic melanoma. a 18FDG-PET-CT scan of the patient when the metastatic disease was diagnosed. b 18FDG-positive lung lesion at the initial diagnosis of metastatic BRAF mutated melanoma. c Initial treatment response to BRAF and MEK inhibitors and to pembrolizumab over time
